Fundz

Allarity Therapeutics, Inc. reported raising $20 Million in an initial SEC Form D filing, from an offering of $40 Million

PUBLIC · ALLRMay 27, 2021$20M of $40M raised

Amount Raised

$20 Million

$20 Million sold, per SEC Form D (first sale May 27, 2021)

Round Type

Venture

BostonManufacturingBiotechnology

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Allarity Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Stimcell Energetics Inc. raised $5K (Pre-Seed) on July 8, 2021.
  • Harvard Apparatus Regenerative Technology raised $600K on June 23, 2021.
  • Celtic Renewables raised $5.2M on June 23, 2021.
  • Brains Bioceutical raised $32M (Funding Round) on June 16, 2021.
  • Bekaert raised $9.4M on June 16, 2021.
  • NIIMBL raised $4.6M (Seed) on June 8, 2021.

Who to call at Allarity Therapeutics, and when

A new round usually means Allarity Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Allarity Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Allarity Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Allarity Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Allarity Therapeutics

Location

24 SCHOOL STREET, 2ND FLOOR

Boston, Massachusetts, United States

About

Allarity Therapeutics, Inc. (NASDAQ: ALLR) is a clinical-stage biopharmaceutical company dedicated to developing personalized cancer treatments. The Company is focused on development of stenoparib, a novel PARP/Tankyrase inhibitor for advanced ovarian cancer patients, using its DRP® companion diagnostic for patient selection in the ongoing phase 2 clinical trial, NCT03878849. Allarity is headquartered in the U.S., with a research facility in Denmark, and is committed to addressing significant unmet medical needs in cancer treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Allarity Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsSteen K., Chief Scientific Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Allarity Therapeutics's next move

See what Strategic adds

Allarity Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.